Brainstorm Cell Therapeutics Inc (BCLI)
0.5647
-0.04
(-5.91%)
USD |
NASDAQ |
Mar 28, 16:00
0.5897
+0.02
(+4.43%)
After-Hours: 20:00
Brainstorm Cell Therapeutics Cash from Investing (TTM): 3.035M for Sept. 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
September 30, 2023 | 3.035M |
June 30, 2023 | 3.036M |
March 31, 2023 | 3.02M |
December 31, 2022 | 0.998M |
September 30, 2022 | -1.337M |
June 30, 2022 | 0.37M |
March 31, 2022 | 0.343M |
December 31, 2021 | 0.323M |
September 30, 2021 | 1.318M |
June 30, 2021 | -0.464M |
March 31, 2021 | -2.495M |
December 31, 2020 | -4.452M |
September 30, 2020 | -4.495M |
June 30, 2020 | -2.97M |
March 31, 2020 | 0.491M |
December 31, 2019 | 5.616M |
September 30, 2019 | 9.929M |
June 30, 2019 | 13.47M |
March 31, 2019 | -0.951M |
December 31, 2018 | -1.218M |
September 30, 2018 | -2.441M |
June 30, 2018 | -14.66M |
March 31, 2018 | 5.151M |
December 31, 2017 | 3.986M |
September 30, 2017 | 2.029M |
Date | Value |
---|---|
June 30, 2017 | 9.553M |
March 31, 2017 | 2.91M |
December 31, 2016 | 5.977M |
September 30, 2016 | 6.087M |
June 30, 2016 | 7.74M |
March 31, 2016 | 7.048M |
December 31, 2015 | -11.28M |
September 30, 2015 | -14.94M |
June 30, 2015 | -18.48M |
March 31, 2015 | -17.93M |
December 31, 2014 | -4.45M |
September 30, 2014 | 3.088M |
June 30, 2014 | 1.655M |
March 31, 2014 | 1.60M |
December 31, 2013 | 2.656M |
September 30, 2013 | -4.89M |
June 30, 2013 | -1.865M |
March 31, 2013 | -1.817M |
December 31, 2012 | -2.84M |
September 30, 2012 | -0.093M |
June 30, 2012 | -0.08M |
March 31, 2012 | -0.08M |
December 31, 2011 | -0.064M |
September 30, 2011 | -0.043M |
June 30, 2011 | -0.044M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-4.495M
Minimum
Sep 2020
13.47M
Maximum
Jun 2019
1.305M
Average
0.37M
Median
Jun 2022
Cash from Investing (TTM) Benchmarks
Outlook Therapeutics Inc | -- |
NovaBay Pharmaceuticals Inc | -0.017M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |
Theriva Biologics Inc | -0.202M |